EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT:

# Drug Count
0 RITUXIMAB 9
1 CYCLOPHOSPHAMIDE 7
2 CYCLOPHOSPHAMIDE FOR INJECTION 7
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 7
4 PREDNISONE 6
5 BENDAMUSTINE HCL 4
6 DOXORUBICIN 2
7 AMOXICILLIN 1
8 BENDAMUSTINE HYDROCHLORIDE 1
9 BISMUTH 1
See all common drugs associated with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT

EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 1 0.0007
1 BENDAMUSTINE HCL 4 0.0003
2 BISMUTH SUBSALICYLATE 1 0.0002
3 IDELALISIB 1 0.0001
4 BENDAMUSTINE HYDROCHLORIDE 1 0.0001
5 PREDNISOLONE ACETATE 1 0.0001
6 RITUXIMAB 9 0.0000
7 CYCLOPHOSPHAMIDE FOR INJECTION 7 0.0000
8 CYCLOPHOSPHAMIDE 7 0.0000
9 DOXORUBICIN 2 0.0000
See all drugs enriched for association with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT

EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bismuth [EPC] 1 0.0002
1 Alkylating Drug [EPC] 7 0.0000
2 CD20-directed Cytolytic Antibody [EPC] 9 0.0000
3 Nitroimidazole Antimicrobial [EPC] 1 0.0000
4 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
5 Corticosteroid [EPC] 7 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
7 Kinase Inhibitor [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT